Nyrada Inc

NYR

Company Profile

  • Business description

    Nyrada Inc is a preclinical-stage, drug discovery, and development company, specializing in novel small-molecule drugs to treat cardiovascular and neurological diseases. The company's two programs center on cholesterol-lowering and brain injury, each targeting market sectors of notable size and unmet clinical needs. The programs are focused on developing an oral, small molecule cholesterol-lowering drug, and a drug to treat secondary brain damage following a stroke or traumatic brain injury.

  • Contact

    828 Pacific Highway
    Suite 2, Level 3
    GordonNSW2072
    AUS

    T: +61 294983390

    https://www.nyrada.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

Stocks News & Analysis

stocks

Will China strong arm BHP into lower iron ore prices?

Allegations that the Chinese government told steel mills to stop buying from BHP shake markets.
stocks

Chart of the Week: Where Morningstar sees attractive dividend yields in 26/27

Charts from the Australian Dividend Outlook show the sectors where they are abundant.
stocks

2 picks in an undervalued ASX sector

Investors may be too pessimistic about this industry.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,276.6019.90-0.21%
CAC 408,041.3618.77-0.23%
DAX 4024,611.2514.120.06%
Dow JONES (US)46,449.37152.41-0.33%
FTSE 1009,509.4039.47-0.41%
HKSE26,752.5976.87-0.29%
NASDAQ23,001.2642.12-0.18%
Nikkei 22548,580.44845.451.77%
NZX 50 Index13,570.862.380.02%
S&P 5006,736.7716.95-0.25%
S&P/ASX 2008,969.8025.20-0.28%
SSE Composite Index3,933.9751.201.32%

Market Movers